Came across this recent article discussing the progress of MSB, and two other ASX listed companies, NOX and DXB, all targeting treatments for covid-19 related ARDS.
https://kalkinemedia.com/au/noxopha...ace-to-develop-covid-19-treatment-nox-msb-dxb
The conclusion of the article mirrors my view of the current worldwide potential of an effective ARDS treatment:
"The rising number of coronavirus cases and non-availability of any specific treatment or vaccine to prevent or treat COVID-19 so far, offer an enormous commercial opportunity for all these healthcare players to discover a successful treatment for the lethal disease. As death rate associated with ARDS caused by any factor (including coronavirus) is considerably high, benefits of a fast-tracked treatment are likely to extend beyond the impact of COVID-19."
Apologies if this has already been posted. Herro
Came across this recent article discussing the progress of MSB,...
-
- There are more pages in this discussion • 13,990 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |